GOLDMAN SACHS GROUP INC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 64 filers reported holding PROQR THRAPEUTICS N V in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2022$117,000
-5.6%
157,910
-1.2%
0.00%
Q2 2022$124,000
-82.3%
159,796
-79.4%
0.00%
Q1 2022$702,000
-97.8%
775,935
-80.2%
0.00%
-100.0%
Q4 2021$31,346,000
+9.1%
3,913,394
+14.0%
0.01%0.0%
Q3 2021$28,726,000
+27.9%
3,432,069
+3.0%
0.01%
+20.0%
Q2 2021$22,462,000
+2.6%
3,332,570
+0.6%
0.01%
-16.7%
Q1 2021$21,896,000
+58.4%
3,312,507
+0.7%
0.01%
+50.0%
Q4 2020$13,822,000
-13.0%
3,291,035
-0.8%
0.00%
-20.0%
Q3 2020$15,888,000
-21.3%
3,316,837
-0.0%
0.01%
-16.7%
Q2 2020$20,176,000
+10.6%
3,318,374
-0.1%
0.01%0.0%
Q1 2020$18,236,000
-45.1%
3,321,703
-0.9%
0.01%
-25.0%
Q4 2019$33,200,000
+73.5%
3,350,192
+0.8%
0.01%
+33.3%
Q3 2019$19,135,000
-37.1%
3,322,107
-0.6%
0.01%
-33.3%
Q2 2019$30,424,000
-37.9%
3,343,322
-5.3%
0.01%
-40.0%
Q1 2019$48,969,000
-8.9%
3,530,568
+3.7%
0.02%
-11.8%
Q4 2018$53,748,000
+33077.8%
3,406,102
+30489.2%
0.02%
Q3 2015$162,000
-13.8%
11,135
-1.2%
0.00%
Q2 2015$188,000
-54.9%
11,273
-40.8%
0.00%
Q1 2015$417,000
+70.9%
19,049
+69.0%
0.00%
Q4 2014$244,00011,2700.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q2 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders